Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

23.71

-0.09 (-0.38%)

At close: Aug 13, 2026, 4:00 PM EDT

23.66

-0.05 (-0.21%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Seaport Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	57.57	20.98	27.35
Research & Development	88.42	66.31	25.07
Total Operating Expenses	145.99	87.29	52.42
Operating Income	-145.99	-87.29	-52.42
Interest Income	10.72	11.4	5.54
Other Non-Operating Income (Expense)	1.96	1.78	-
Total Non-Operating Income (Expense)	12.68	13.19	5.54
Pretax Income	-133.31	-74.11	-46.88
Provision for Income Taxes	1.38	0.77	-
Net Income	-134.69	-74.88	-46.88
Net Income to Common	-134.69	-74.88	-46.88
Net Income Growth	-	-	-
Shares Outstanding (Basic)	11	2	1
Shares Outstanding (Diluted)	11	2	1
Shares Change	-	151.76%	-
EPS (Basic)	-31.61	-31.54	-49.72
EPS (Diluted)	-31.61	-31.54	-49.72
EPS Growth	-	-	-
Free Cash Flow	-88.76	-78.3	-29.74
Free Cash Flow Growth	-	-	-
Free Cash Flow Per Share	-8.35	-32.98	-31.54
EBITDA	-145.84	-87.12	-52.25
EBIT	-145.99	-87.29	-52.42
Effective Tax Rate	-1.03%	-1.04%	0.00%

SEC Filings: 10-K · 10-Q